Class IIOngoing

Timolol Maleate Ophthalmic Solution USP recall

FDA recall D-0114-2025 · initiated Dec 5, 2024

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.

Details

Product: Timolol Maleate Ophthalmic Solution USP, 0.25%, Sterile, 15mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, NDC 64980-513-15.
Recalling company: Fdc Ltd
Classification: Class II
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: Distributed to one Us Distributor in NJ.
Initiated: Dec 5, 2024
FDA report date: Dec 18, 2024

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0114-2025 ↗

← All drug recalls